Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Working Capital/Sales

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 1.551.531.832.303.11

What is the latest Working Capital/Sales ratio of MARKSANS PHARMA ?

The latest Working Capital/Sales ratio of MARKSANS PHARMA is 1.55 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.55
Mar20231.53
Mar20221.83
Mar20212.30
Mar20203.11

How is Working Capital/Sales of MARKSANS PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 1.55
1.31
Mar2023 1.53
-16.39
Mar2022 1.83
-20.43
Mar2021 2.3
-26.05
Mar2020 3.11 -

Other Financial Ratios of MARKSANS PHARMA


Compare Working Capital/Sales ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹13,485.0 Cr 3.6% -13.8% 85.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹443,661.0 Cr -1.8% 2.7% 49.1% Stock Analytics
DIVIS LABORATORIES ₹160,496.0 Cr -0.2% -3.4% 57% Stock Analytics
CIPLA ₹121,970.0 Cr -0.7% 0.6% 22.9% Stock Analytics
DR REDDYS LABORATORIES ₹112,877.0 Cr -1.8% 11.3% 18% Stock Analytics
ZYDUS LIFESCIENCES ₹98,163.2 Cr 1.9% 0.5% 41.9% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

3.6%

-13.8%

85.3%

SENSEX

0.7%

-2%

9.7%


You may also like the below Video Courses